IQ4I Research & Consultancy Published a New Report on Biochips (Microarrays/Lab-on-Chip) Global Market
Summary
Potential countervailing factors include stringent government regulations, lack of skilled personnel to perform biochips techniques, and high cost of some of the commercial instruments, supposed to hamper the market growth.Significant mergers and acquisitions, collaborations, joint ventures are the industry trends that are playing a major role for the market growth.Major players in biochips market include Affymetrix, Inc. (U.S.), Agilent Technologies (U.S.), Bio-Rad Laboratories (U.S.), Cepheid, Inc. (U.S.), Fluidigm Corporation (U.S.), GE Healthcare (U.K.), Hoffman-La-Roche (Switzerland), Illumina, Inc. (U.S.), PerkinElmer, Inc. (U.S.) and Thermo Fisher Scientific, Inc. (U.S.).Illumina is a dominant player with a share of XX%, followed by Cepheid, Inc., Affymetrix, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies, Roche and Fluidigm Corporation.Potential countervailing factors include stringent government regulations, lack of skilled personnel to perform biochips techniques, and high cost of some of the commercial instruments, supposed to hamper the market growth.